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SUMMARY
We used the clustered lot quality assurance sampling (clustered-LQAS) technique to identify
districts with low immunization coverage and guide mop-up actions during the last 4 days of a
combined oral polio vaccine (OPV) and yellow fever (YF) vaccination campaign conducted in
Cameroon in May 2009. We monitored 17 pre-selected districts at risk for low coverage. We
designed LQAS plans to reject districts with YF vaccination coverage<90% and with OPV
coverage<95%. In each lot the sample size was 50 (ﬁve clusters of 10) with decision values of 3
for assessing OPV and 7 for YF coverage. We ‘rejected’ 10 districts for low YF coverage and 14
for low OPV coverage. Hence we recommended a 2-day extension of the campaign. Clustered-
LQAS proved to be useful in guiding the campaign vaccination strategy before the completion of
the operations.
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INTRODUCTION
Vaccination campaigns targeting disease elimination
aim to achieve very high levels of coverage, up to 95%
in every district. To rapidly assess areas that are not
reaching these very high levels of coverage during
vaccination campaign activities, rapid house-to-house
monitoring (RHHM) has been proposed [1]. RHHM
has the advantages of being practical and fast, but its
statistical value may be diﬃcult to interpret since the
sample is not randomly selected (it uses a convenience
sample approach).
The World Health Organization (WHO) has been
using the lot quality assurance sampling (LQAS)
method to classify areas of interest (lots) as having
reached acceptable or unacceptable levels of vacci-
nation coverage [2]. LQAS uses two coverage thresh-
olds, an upper threshold (UT) and a lower threshold
(LT), and a decision value (d) in a sample (N) of the
population. The area between the UT and the LT is
known as the ‘grey area’ and is the area of statistical
uncertainty typical of LQAS designs: if the number of
unvaccinated individuals found in N is higher than d,
then we reject the lot as not having reached acceptable
vaccination coverage (i.e. real coverage in the lot is
below UT); if it is equal to or less than d, then we
accept it as acceptable coverage (i.e. real coverage in
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the lot is above LT). The alpha error is the probability
of accepting a lot with an unacceptable proportion
of unvaccinated individuals, while the beta error is
the probability of rejecting a lot with acceptable vac-
cination coverage [3]. The larger the grey area, the
smaller the sample size needed to assess the lot with
equal precision [4].
LQAS classiﬁcation traditionally relies on simple
random sampling (SRS) and small sample sizes
(N<20), this is feasible if the lots are small areas (e.g. a
city neighbourhood) where individuals can be easily
sampled randomly, but it can become very time-
consuming if the lots are large [5, 6]. Instead of SRS,
cluster sampling can be used in the lots as an
alternative method to reduce the number of site visits
needed to complete data collection [4]. Previous
studies have explored the applications of clustering
the LQA sample to assess global acute malnutrition
using ﬁeld data and computer simulations [7–9].
A similar approach based on computer simulations to
assess the precision of LQAS plans divided into
smaller clusters (Clustered-LQAS) has also been
explored to assess vaccination coverage [4]. Clustered-
LQAS has proven to be useful in assessing vacci-
nation coverage at the health district level after
completion of immunization activities [10], but has
not previously been used to monitor performance
before the end of a campaign in order to identify areas
that require mop-up activities and ensure achievement
of objectives.
Between 4 and 11 May 2009, Cameroon conducted
a polio and yellow fever (YF) vaccination campaign.
The target population for YF vaccination was 90% of
the 7.5 million individuals aged o9 months (except
pregnant women) in 62 health districts at risk for YF
[11]. The target population for the oral polio vacci-
nation (OPV) was 100% of the 2.9 million children
aged between 0 and 59 months in all 173 health
districts of Cameroon.
YF is a mosquito-borne viral haemorrhagic fever
endemic in the equatorial regions of Africa and South
America [12–14]. Resurgence of YF virus in recent
years poses a public health threat due to the potential
for devastating urban epidemics [15, 16]. Cameroon
is one of the 12 African countries supported by the
Yellow Fever Initiative led by the WHO and the
United Nations Children’s Fund (UNICEF) with
funding from the Global Alliance for Vaccines
and Immunization (GAVI) [11, 15, 17]. Poliomyelitis
(polio) is a viral disease that aﬀects the nervous system
[18]. Polio is targeted for worldwide eradication but,
as of 2010, remains endemic in Afghanistan, India,
Pakistan, and Nigeria, with sporadic cases exported
to other countries [18–21]. At the time of the vacci-
nation campaign, Cameroon had not reported any
polio cases since 2006, although cases occurred in
neighbouring Nigeria, Chad, and Central African
Republic [22].
The purpose of our study was to use the clustered-
LQAS technique for mid-campaign vaccination
coverage monitoring, and thereby assess districts in
Cameroon at risk of low YF or polio vaccination
coverage in order to implement timely measures to
improve performance before the end of the campaign.
MATERIALS AND METHODS
Deﬁnitions
For the purpose of the clustered-LQAS survey, we
deﬁned the health districts in Cameroon as ‘ lots ’. We
deﬁned an individual vaccinated against YF as a
person aged o9 months, not pregnant, presenting a
YF vaccination card from the current campaign or
prior vaccination. We deﬁned an individual vacci-
nated against polio as a child aged between 0 and
59 months presenting the indelible ink mark on the
ﬁngernail at the time of OPV vaccination. In the
absence of card or ink mark, we recorded a verbal
history of vaccination.
Clustered-LQAS plans
As the YF vaccination coverage target was 90%,
we used this level for the UT and 75% as the LT,
selecting a decision value of seven in a sample of 50
individuals. Assuming SRS, the alpha value of this
plan was 5% and the beta value 24%. For polio we
set the UT to 95% and the LT to 85%, with d=3 and
N=50. Assuming SRS, the alpha and beta values of
the plan used for polio were 5% and 12%, respect-
ively.
In the ﬁeld, we did not use SRS but we divided each
sample (N=50) into ﬁve clusters of 10 individuals
according to the clustered-LQAS methodology [4].
To investigate the eﬀect of clustering, we recalculated
alpha and beta by conducting simulations where each
cluster’s true coverage was sampled from a binomial
distribution with a mean of LT or UT and standard
deviations (S.D.) of 0.05 or 0.10 (Table 1) [4].
We calculated the operating characteristic (OC)
curves of the sampling plans used to assess YF (Fig. 1)
and OPV (Fig. 2) coverage according to SRS and
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the two 5r10 clustered designs (S.D.=0.05 and
S.D.=0.10).
Lot selection
As the approach was designed to detect low vacci-
nation coverage during the campaign to allow time
for intervention, all 62 target districts were assessed
before the campaign based on local data. The re-
sources available did not allow us to assess all 62
target districts, we therefore decided to prioritize
the districts for intervention. We selected a subset of
districts (17/62) at risk for low coverage, of which 12
were selected before the campaign and ﬁve once the
campaign had begun.
Based on the indicators used by WHO [23], we de-
ﬁned seven criteria for risk of low coverage :
(1) Routine infant administrative YF vaccination
coverage in 2008 with S.D. above (i.e. above
100%) or below the mean coverage in the 62 dis-
tricts targeted by the campaign, reﬂecting a poss-
ible problem with population estimates in the
district, which would make administrative cover-
age data unreliable.
(2) Routine OPV-3 administrative coverage in 2008
with S.D. above or below the mean coverage in the
districts.
(3) A district population estimate with S.D. above the
mean population in the districts, reﬂecting large
Table 1. Sampling plans used to evaluate coverage of the two vaccines,
clustered lot quality assurance sampling survey of yellow fever and polio
vaccination coverage, Cameroon, May 2009
Vaccine N d LT (%) UT (%) Clusters S.D. Alpha (%) Beta (%)
OPV 50 3 85 95 — — 5 24
5r10 0.05 6 26
5r10 0.1 10 30
YFV 50 7 75 90 — — 5 12
5r10 0.05 6 15
5r10 0.1 8 19
N, Sample size ; d, decision value ; LT, lower threshold ; UT, upper threshold;
OPV, oral polio vaccine ; YFV, yellow fever vaccine ; S.D., standard deviation.
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Fig. 1. Operating characteristic curves for lot quality assurance sampling rule-rejecting programmes with more than seven
defectives in a sample of 50, according to simple random sampling (SRS) and the two 5r10 clustered designs (S.D.=0.05 and
S.D.=0.10).
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or densely populated districts that may present
unique challenges.
(4) A drop-out rate between the ﬁrst and third doses
of routine infant DTP-HepB vaccine above 10%,
reﬂecting problematic routine immunization ser-
vices [24].
(5) The district has a border with a neighbouring
country; in this case, cross-border inﬂux of per-
sons seeking vaccination could mask a low
coverage in the resident population of the district.
(6) District with a complex situation, such as conﬂict,
hosting refugees or internally displaced persons or
other circumstances that could challenge cam-
paign implementation.
(7) Previous campaigns resulted in low immunization
coverage in the district ; some districts may regu-
larly have diﬃculties achieving national pro-
gramme targets for a variety of reasons.
We assigned a point each time a district fulﬁlled one
of the criteria and selected the 12 districts with the
highest rank, ensuring that all the target regions of
Cameroon and the two main cities Yaounde´ and
Douala, were represented by at least one district. We
selected the remaining ﬁve districts from those re-
porting the lowest preliminary YF administrative
coverage on the second day of the campaign (Table 2).
Sampling and data collection
Since our objective was to use clustered-LQAS for
mid-campaign evaluation, we conducted the survey
during the last 4 days of the campaign (days 5–8). For
each antigen, we interviewed 50 eligible individuals
per lot (district) for vaccination status, divided into
ﬁve clusters of 10. In each district we randomly
selected ﬁve health areas. In each health area we ran-
domly selected a locality (village or neighbourhood).
Next, we randomly selected the ﬁrst household in the
cluster according to geographic random sampling: we
drafted a map of the locality, divided it into smaller
sectors according to existing divisions (streets, rivers,
etc.), and randomly selected one sector where we
chose the most central household to start the survey.
In the selected household, we interviewed for YF
vaccination status only one eligible individual ran-
domly selected and all eligible individuals for OPV. If
the individuals selected were aged<10 years we asked
a parent or caregiver to answer the questions on their
behalf. We then moved to the right of the household
to select the subsequent households following a pre-
determined step. Based on the experience from pre-
vious national household surveys in Cameroon and
on the proportion of each target group in the popu-
lation, the step used was nine households for YF and
three for polio in rural areas; 18 for YF and six for
polio in urban areas.
Since the campaign was in progress, we ensured
that the survey was conducted in the localities already
covered by vaccination activities, by instructing sur-
veyors to obtain this information at district level. If a
selected locality had not yet been covered, surveyors
waited until the last day of the evaluation to cover it
1·0
0·9
0·8
0·7
0·6
0·5
0·4
0·3
0·2
0·1
0
5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 99
Pr
ob
ab
ilit
y
Coverage (%)
P accept SRS
P accept 5×10 S.D.=0·05
P reject 5×10 S.D.=0·05
P accept 5×10 S.D.=0·1
P reject 5×10 S.D.=0·1
P reject SRS
Fig. 2. Operating characteristic curves for lot quality assurance sampling rule-rejecting programmes with more than three
defectives in a sample of 50, according to simple random sampling (SRS) and the two 5r10 clustered designs (S.D.=0.05 and
S.D.=0.10).
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with the clustered-LQAS survey. We used two stan-
dardized questionnaires for data collection.
We did not stop sampling once the number of un-
vaccinated individuals exceeded d in the lot (i.e. the lot
was rejected), and we always completed the sample
(N=50).
Administrative vaccination coverage
Tally sheets were used to record the number of per-
sons vaccinated each day and data were transmitted
daily through each level of the health system. Thus
administrative coverage ﬁgures were available day by
day during the campaign.
Planning the clustered-LQAS surveys in the ﬁeld
The LQAS study team planned the mid-campaign
evaluation in collaboration with the campaign
coordination committee at central level. Campaign
technical supervisors were sent to coordinate the
campaign at regional level and were fully aware of the
purposes of the LQAS surveys. During the mid-
campaign evaluation, the LQAS survey teams were
instructed to participate at the daily vaccination
campaign meetings at district level and discuss the
daily results of LQAS with the health oﬃcers. The
purpose of these meetings was to interpret all infor-
mation from the ﬁeld to guide the ﬁnal eﬀorts of the
campaign. LQAS supervisors also sent telephone text
messages on the performance of each health district
undergoing evaluation every day and especially dur-
ing an emergency when the district was rejected (as
soon as d was exceeded in the lot). In the rejected lots,
the campaign coordination committee recommended
immediate mop-up activities and also considered an
extension of vaccination activities.
Data analysis
The statistical simulations for calculation of the clus-
tered-LQAS plans were run with Stata [25]. We en-
tered data in Epidata [26] and analysed it with Stata
[25]. During the campaign, in order to take corrective
action based on objective information, we considered
as unvaccinated any individual not presenting proof
of vaccination. At a later stage, we also analysed
whether accepting verbal information on vaccination
status would have aﬀected our decision.
We analysed the impact of the measures taken fol-
lowing the outcomes of the clustered-LQAS on YF
administrative coverage. We compared districts with
Table 2. Classiﬁcation for being at risk of low coverage and yellow fever vaccination coverage in the 17 districts
retained for the clustered lot quality assurance sampling survey, Cameroon, May 2009
Region District
Low coverage
risk classiﬁcation*
Administrative
YFV coverage
on day 5 (%)
Final administrative
YFV coverage (%)
West Bangante´ 3 67.7 87.8
North Tchollire´ 2 87.2 104.9
Extreme North Maroua Urban LC-D2# 93.1 124.1
Ve´le´ LC-D2 67.5 125.6
Yagoua 3 48.0 105.7
Kousseri 3 49.9 75.4
Koza 3 64.2 88.0
Mogode´ 3 77.2 129.7
East Garoua Boulaı¨ 3 83.2 99.4
Nguelemendouka LC-D2 60.8 91.3
South Djoum 1 94.6 96.5
Centre Mbandjock LC-D2 71.5 95.3
Baﬁa 3 48.5 69.4
Adamaoua Djohong 2 81.3 94.5
Douala New Bell 3 77.5 93.1
Yaounde´ Biyem Assi 3 66.8 107.6
Cite´ Verte LC-D2 72.6 103.3
YFV, Yellow fever vaccination.
* Numbers 1–3 reﬂect the number of risk criteria for low vaccination coverage, assessed prior to the campaign.
# LC-D2, Lowest administrative YFV coverage at campaign day 2.
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or without intervention with regards to the mean
preliminary YF administrative coverage reported at
day 5 of the campaign and the ﬁnal administrative
coverage at the end of the campaign in the two
groups, using the Wilcoxon/Mann–Whitney test with
Pf0.05 as threshold for statistical signiﬁcance.
We also calculated the standard error (S.E.) from
the mean lot coverage for the proportion vaccinated
in the ﬁve clusters as a measure of inter-cluster varia-
bility and checked if this exceeded the S.D. of 0.05 and
0.1 from the mean lot coverage hypothesized in the
statistical simulations. We used the maximum stan-
dard errors found in the lots as the measure of inter-
cluster variability to recalculate alpha and beta with
the simulation program.
RESULTS
Evaluation of OPV coverage
Of the 17 surveyed districts, 14 (82.4%) were rejected
for low OPV coverage on day 5 of the vaccination
campaign due to exceeding the threshold of three un-
vaccinated individuals, based on documented vacci-
nation status. Allowing verbal report of vaccination,
we would have rejected 11 (64.7%) (Table 3).
Evaluation of YF vaccination coverage
Ten districts (58.8%) were rejected for low YF vac-
cination coverage by the LQAS rule due to exceeding
the threshold of seven unvaccinated individuals,
based on documented vaccination status. Allowing
verbal report of vaccination, we would have rejected
seven districts (41.2%) (Table 4).
Control measures
Measures were taken at district level to increase
OPV and YF vaccination coverage before the end of
the campaign in the rejected lots and, given the high
proportion of rejected districts across Cameroon, a
2-day extension of the campaign was recommended
nationally to increase vaccine coverage.
Intervention analysis
The ﬁnal administrative coverage was 96.3%
nationally for OPV and 100.5% for YF. The mean
increase in the ﬁnal YF administrative vaccination
coverage levels compared with day 5 was higher in the
10 districts initially rejected [mean increase 51.3%,
95% conﬁdence interval (CI) 27.3–75] than in the
seven accepted ones (mean increase 31.5%, 95% CI
16.9–46.1), although the diﬀerence was not statisti-
cally signiﬁcant. The initially rejected districts ap-
peared to have a signiﬁcantly higher (P=0.05) ﬁnal
YF administrative vaccination coverage (mean ad-
ministrative coverage 106.4%, 95% CI 95.3–117.4)
compared to the accepted ones (mean administrative
coverage 89.7%, 95% CI 77.9–101.5) (Table 2).
Inter-cluster variability
Among the districts evaluated for YF vaccination
coverage, the S.E. of the distribution of the binary
variable vaccinated/unvaccinated in the ﬁve clusters
within the lots ranged between 0 and 0.19. It exceeded
0.1 in 23.5% (4/17) of lots ; in 41.2% (7/17) it was
between 0.05 and 0.1, and in 35.3% (6/17) it was
below 0.05.
Among the districts evaluated for OPV coverage,
the S.E. of the distribution of the binary variable vac-
cinated/unvaccinated in the ﬁve clusters within the
lots also ranged between 0 and 0.19. In 10/17 (58.8%)
lots it exceeded 0.1; in 5/17 (29.4%) it was between
0.05 and 0.1, and in 2/17 (11.8%) it was below 0.05.
Setting 0.19 inter-cluster variability in the simula-
tions, gave alpha=17% and beta=26% in the YF
plan; while in the OPV plan alpha was 20% and it
was not possible to calculate beta since 0.19 varia-
bility around the 95% upper threshold did not ﬁt in
the simulations.
DISCUSSION
During the YF and polio vaccination campaign in
Cameroon, we used clustered-LQAS [4] to assess
vaccination coverage in 17 lots (health districts) pur-
posely selected as being at higher risk for inadequate
coverage. The proportion of districts rejected as having
low coverage was high: 59% for YF vaccination and
82% for OPV, using the vaccination card or ﬁngernail
mark as proof of vaccination. Based on these ﬁndings
a 2-day extension of the campaign was recommended
nationally by the Ministry of Health to increase vac-
cination coverage. The districts initially rejected for
low YF vaccination coverage presented a signiﬁcantly
higher ﬁnal administrative YF vaccination coverage
compared to those initially accepted, suggesting that
interventions to increase coverage at district level and
nationally may have been eﬀective.
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Table 3. Oral polio vaccination coverage ﬁndings of clustered lot quality assurance sampling survey, Cameroon,
May 2009
Lot Clusters
No. unvaccinated
with OPV – ﬁngernail
ink mark absent
(decision)
S.E. of the distribution
of the vaccination
variable (mark) between
the clusters in the lots
No. unvaccinated
with OPV – by verbal
report (decision)
S.E. of the distribution
of the vaccination variable
(verbal report) between the
clusters in the lots
Bangante´ 1 6 1
2 3 0
3 0 0
4 0 0
5 8 3
Total 17 (R) 0.16 4 (R) 0.06
Tchollire´ 1 0 0
2 3 3
3 0 0
4 0 0
5 0 0
Total 3 (A) 0.06 3 (A) 0.06
Maroua Urban 1 4 0
2 5 2
3 3 3
4 0 0
5 7 7
Total 19 (R) 0.12 12 (R) 0.13
Ve´le´ 1 3 0
2 3 1
3 1 0
4 9 7
5 1 0
Total 17 (R) 0.15 8 (R) 0.14
Yagoua 1 6 4
2 1 1
3 8 5
4 7 4
5 0 0
Total 22 (R) 0.16 14 (R) 0.10
Kousseri 1 1 2
2 6 3
3 9 0
4 8 1
5 2 0
Total 26 (R) 0.16 6 (R) 0.06
Koza 1 0 0
2 3 3
3 5 3
4 3 0
5 0 0
Total 11 (R) 0.10 6 (R) 0.07
Mogode´ 1 0 0
2 0 0
3 0 0
4 1 1
5 0 0
Total 1 (A) 0.02 1 (A) 0.02
Garoua Boulaı¨ 1 0 0
2 0 0
3 0 0
4 0 0
5 0 0
Total 0 (A) 0 0 (A) 0
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Table 3 (cont.)
Lot Clusters
No. unvaccinated
with OPV – ﬁngernail
ink mark absent
(decision)
S.E. of the distribution
of the vaccination
variable (mark) between
the clusters in the lots
No. unvaccinated
with OPV – by verbal
report (decision)
S.E. of the distribution
of the vaccination variable
(verbal report) between the
clusters in the lots
Nguelemendouka 1 2 2
2 0 0
3 6 0
4 0 0
5 0 0
Total 8 (R) 0.12 2 (A) 0.04
Djoum 1 10 2
2 1 1
3 4 1
4 10 0
5 2 2
Total 27 (R) 0.19 6 (R) 0.04
Mbandjock 1 9 6
2 9 0
3 5 5
4 6 4
5 10 1
Total 39 (R) 0.10 16 (R) 0.12
Baﬁa 1 3 2
2 2 0
3 0 0
4 2 0
5 10 0
Total 17 (R) 0.17 2 (A) 0.04
Djohong 1 0 0
2 5 4
3 0 0
4 2 0
5 10 10
Total 17 (R) 0.19 14 (R) 0.20
New Bell 1 3 1
2 0 0
3 3 0
4 0 0
5 2 0
Total 8 (R) 0.07 1 (A) 0.02
Biyem Assi 1 6 3
2 1 1
3 5 3
4 3 1
5 3 1
Total 18 (R) 0.09 9 (R) 0.05
Cite´ verte 1 0 0
2 8 3
3 3 1
4 8 4
5 5 4
Total 24 (R) 0.15 12 (R) 0.08
OPV, Oral polio vaccine ; S.E., standard error ; R, rejected ; A, accepted.
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Table 4. Yellow fever vaccination coverage ﬁndings of clustered lot quality assurance sampling survey,
Cameroon, May 2009
Lot Clusters
Number
unvaccinated – no
YFV card
(decision)
S.E. of the distribution
of the vaccination
variable (card) between
the clusters in the lots
Number
unvaccinated – verbal
report (decision)
S.E. of the distribution
of the vaccination variable
(verbal report) between
the clusters in the lots
Bangante´ 1 3 0
2 1 0
3 5 2
4 2 1
5 5 2
Total 16 (R) 0.08 5 (A) 0.04
Tchollire´ 1 3 0
2 0 0
3 0 0
4 1 0
5 2 0
Total 6 (A) 0.06 0 (A) 0
Maroua Urban 1 2 1
2 4 2
3 1 1
4 1 1
5 4 4
Total 12 (R) 0.07 9 (R) 0.06
Ve´le´ 1 5 4
2 4 3
3 5 5
4 6 4
5 4 4
Total 24 (R) 0.04 20 (R) 0.03
Yagoua 1 10 1
2 1 1
3 8 4
4 3 1
5 1 1
Total 23 (R) 0.19 8 (R) 0.06
Kousseri 1 0 0
2 0 0
3 1 0
4 1 0
5 0 0
Total 2 (A) 0.02 0 (A) 0
Koza 1 1 1
2 3 3
3 7 0
4 1 1
5 3 0
Total 15 (R) 0.11 5 (A) 0.05
Mogode´ 1 2 2
2 0 0
3 0 0
4 2 2
5 4 3
Total 8 (R) 0.07 7 (A) 0.06
Garoua Boulaı¨ 1 0 0
2 0 0
3 0 0
4 0 0
5 0 0
Total 0 (A) 0 0 (A) 0
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Table 4 (cont.)
Lot Clusters
Number
unvaccinated – no
YFV card
(decision)
S.E. of the distribution
of the vaccination
variable (card) between
the clusters in the lots
Number
unvaccinated – verbal
report (decision)
S.E. of the distribution
of the vaccination variable
(verbal report) between
the clusters in the lots
Nguelemendouka 1 0 0
2 0 0
3 4 4
4 0 0
5 0 0
Total 4 (A) 0.08 4 (A) 0.08
Djoum 1 4 2
2 3 3
3 1 1
4 3 3
5 4 1
Total 15 (R) 0.05 10 (R) 0.04
Mbandjock 1 10 1
2 4 3
3 6 1
4 3 1
5 10 2
Total 33 (R) 0.15 8 (R) 0.04
Baﬁa 1 1 1
2 2 2
3 0 0
4 1 1
5 1 1
Total 5 (A) 0.03 5 (A) 0.03
Djohong 1 0 0
2 1 0
3 0 0
4 0 0
5 0 0
Total 1 (A) 0.02 0 (A) 0
New Bell 1 2 2
2 1 1
3 1 1
4 0 0
5 0 0
Total 4 (A) 0.04 4 (A) 0.04
Biyem Assi 1 7 4
2 4 4
3 3 3
4 2 1
5 4 2
Total 20 (R) 0.08 14 (R) 0.06
Cite´ Verte 1 4 3
2 3 1
3 4 2
4 6 5
5 9 9
Total 26 (R) 0.11 20 (R) 0.14
YFV, Yellow fever vaccination ; S.E., standard error ; R, rejected ; A, accepted.
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We used clustered-LQAS for mid-campaign evalu-
ation; while this approach allows time to implement
mop-up activities, undertaking an assessment based
on ﬁnal targets before the end of the time allocated
to achieve the target will evidently result in under-
estimation of coverage. To overcome this limitation,
we instructed surveyors to ﬁrst survey the selected
localities already covered by vaccination, especially
during the ﬁrst day of the evaluation. It was, however,
diﬃcult in some cases to establish which localities
were covered at lower administrative levels while in
the ﬁeld.
Relying on verbal conﬁrmation of vaccination sta-
tus, we would have rejected fewer districts : 41% for
YF vaccination and 65% for OPV. The possible
overestimation of vaccination coverage using verbal
conﬁrmation is a potential problem during the evalu-
ation of vaccination activities [27, 28]. We therefore
opted to base operational conclusions on reliable
vaccination information to increase the likelihood of
timely evidence-based intervention. The frequent ab-
sence of documented proof of vaccination was sur-
prising since the evaluation was conducted during the
campaign when card retention should still be high,
suggesting a failure in ensuring adequate supply, de-
livery and use of vaccination cards and ﬁnger-mark-
ing during the campaign.
We explored dividing lots into ﬁve clusters, rather
than using SRS, to increase the feasibility and timeli-
ness of LQAS conducted at district level and re-
calculated the statistical errors using computer
simulations [4]. Although this did not happen in
Cameroon, with decision values of three and seven in
a 5r10 sample, it may be diﬃcult to justify the de-
cision on the whole lot if d is exceeded only in one
cluster, especially in the case of villages selected as
clusters completely missed by vaccination. To over-
come this limitation, it is important to interpret the
clustered-LQAS ﬁndings with other data including
the administrative coverage and local information.
In a previous experience with this approach, we
were reassured of the homogeneity of the territory
through calculating inter-cluster correlation (ICC) of
ﬁeld data [10]. In this study, clusters were too few and
small to calculate any reliable ICCs. Therefore, we
accounted for clustering in each lot by calculating the
S.E. of the proportion of vaccinated in the clusters, as
a measure of inter-cluster variability, which exceeded
0.1 in 23.5% of the lots assessed for YF coverage and
in 58.8% of the lots assessed for OPV coverage.
Assuming that the maximum inter-cluster variability
in the lots was really S.E.=0.19, this would have pro-
duced unreliable decision rules with alpha up to 17%
and beta up to 26% (yellow fever plan) and with
alpha up to 20% and beta theoretically up to 100%
(OPV plan). This conﬁrms that clustered-LQAS is
unreliable if the territory under study is very hetero-
geneous with regard to immunization coverage and
that the S.D. from the mean lot coverage is>0.1 in the
clusters [4].
The higher proportion of districts rejected for low
OPV coverage suggests that the polio campaign was
less successful than the YF campaign in reaching the
target. However this may also depend on the sampling
plan used for OPV. To keep N to a manageable size,
allowing also for clustering, we had to be more toler-
ant towards the risk of error [29]. We gave priority to
keeping alpha lower rather than beta, especially in the
OPV plan, preferring to be strict in not accepting
districts with low coverage (a risk for the population),
rather than to reject districts with good coverage
(a risk for the healthcare system) [30]. Such a study
design may have produced a higher proportion of
false positives (districts with high coverage rejected by
the LQAS rule) rather than false negatives (districts
with low coverage accepted by the LQAS rule) [31]. In
addition the polio plan had a shorter grey area (10%)
that increased the risk of error considerably and also
the sampling strategy used, which recommended
sampling all the individuals in the target group in the
selected household, rather than selecting one ran-
domly, may have increased clustering and the likeli-
hood of error.
To select lots for assessment, we calculated the S.D.
from the mean administrative vaccination coverage
in all the districts targeted by the campaign to assess
if districts may have been presenting vaccination
coverage below or above that expected, thus being
at risk of low vaccination coverage. Although this
approach is standardized and reproducible, it may be
more practical to agree on ﬁxed vaccination coverage
thresholds that should always be used in diﬀerent
settings in order to increase the practicality of the
risk assessment. The pre-selection of two thirds of
districts according to available information allowed
for maximizing eﬃciency in preparing the survey,
while reserving the option of deploying teams to ad-
ditional districts based on early vaccination data also
ensured the immediate operational relevance of the
exercise.
Although our study suggests that the clustered-
LQAS survey may have been eﬀective in improving
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coverage (especially in rejected districts), it is diﬃcult
to demonstrate this statistically given the small
sample of 17 districts and the fact that at-risk districts
were purposefully selected. It would be useful to check
if results of other monitoring tools are consistent with
the clustered-LQAS ﬁndings and compare the results
of the simulation with real ﬁeld data [9]. This was not
possible as household and external convenience
monitoring were not done in the same districts as the
clustered-LQAS survey, and the ﬁnal vaccination
coverage survey was administered at regional not
district level [32], therefore we opted to compare the
two diﬀerent plans used (OPV and YF) with each
other.
This is the ﬁrst experience using clustered-LQAS in
the ﬁeld since this new variant of the methodology has
been standardized [4]. The use of clustered-LQAS for
mid-campaign evaluation was successful in monitor-
ing the progress of the campaign in at-risk districts,
allowing authorities to implement timely interven-
tions in the rejected lots. Reasons why a district was
rejected may have been: poor micro-planning, failure
of social mobilization, or accessibility problems.
Dividing the survey sample in each lot into ﬁve
small clusters increased operational feasibility, while
respecting the scientiﬁc rationale underpinning the
LQAS methodology. We recommend the use of clus-
tered-LQAS as an operational tool to guide the ﬁnal
eﬀorts of vaccination campaigns. To ensure suﬃcient
precision of the clustered-LQAS plans we recommend
keeping the grey area in the plans to at least 15% if
users want to divide the sample in ﬁve clusters. We
recommend clustered-LQAS to evaluate immuniz-
ation programmes that perform well, where it is
unlikely to ﬁnd villages completely missed by vacci-
nation activities. To improve accuracy of the assess-
ment, the survey should be implemented as close to
the end of the campaign as possible, while still allow-
ing time for operational decision-making to im-
plement mop-up activities. We recommend improved
planning and monitoring for the logistics and distri-
bution of proof of vaccination (cards or ink mark as
appropriate) and inclusion of card retention as a key
message for the public during social mobilization. The
LQAS component should be included in the planning
of the campaign and the tools adapted accordingly
(e.g. plan extra days in the tally sheets for adminis-
trative vaccine coverage monitoring in case the dis-
trict is rejected). Further reﬁnement of this method
may be necessary to decide on intermediate coverage
thresholds lower than the campaign coverage target,
based on the experience of the country. Further
studies could compare the use of clustered-LQAS
with other monitoring tools in the same target popu-
lation to verify consistency of results [1, 9]. The results
of the clustered-LQAS conducted during the cam-
paign could also be validated with the results of
the post-campaign coverage surveys [33] if these are
planned in the same territory to evaluate the cam-
paign. The performance of clustered-LQAS plans
divided in more than ﬁve clusters could also be tested
in the ﬁeld.
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